BioCryst Pharmaceuticals Inc (BCRX)
4.15
-0.01
(-0.24%)
USD |
NASDAQ |
Apr 26, 16:00
4.15
0.00 (0.00%)
After-Hours: 19:07
BioCryst Pharmaceuticals Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2020 | -0.431M |
September 30, 2020 | 0.00 |
June 30, 2020 | -92.85M |
March 31, 2020 | |
December 31, 2019 | -58.50M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | -53.40M |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | -0.50M |
September 30, 2017 | -85.75M |
June 30, 2017 | 0.00 |
March 31, 2017 | -47.75M |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 1.175M |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | -1.175M |
December 31, 2014 | 0.00 |
Date | Value |
---|---|
September 30, 2014 | 0.00 |
June 30, 2014 | -106.60M |
March 31, 2014 | |
December 31, 2013 | 0.015M |
September 30, 2013 | -18.48M |
June 30, 2013 | -4.811M |
March 31, 2013 | -0.36M |
December 31, 2012 | 0.006M |
September 30, 2012 | -2.472M |
June 30, 2012 | -3.661M |
March 31, 2012 | -11.68M |
December 31, 2011 | -0.821M |
September 30, 2011 | -0.109M |
June 30, 2011 | 0.073M |
March 31, 2011 | -0.109M |
December 31, 2010 | 0.283M |
September 30, 2010 | -0.109M |
June 30, 2010 | 0.002M |
March 31, 2010 | -0.171M |
December 31, 2009 | -45.58M |
September 30, 2009 | -0.103M |
June 30, 2009 | -0.001M |
March 31, 2009 | -0.09M |
December 31, 2008 | 0.3735M |
September 30, 2008 | -0.166M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-92.85M
Minimum
Jun 2020
--
Maximum
Jun 2019
-25.30M
Average
-0.2155M
Median
Stock Buybacks (Quarterly) Benchmarks
AIM ImmunoTech Inc | -0.147M |
Perspective Therapeutics Inc | -0.364M |
Protalix BioTherapeutics Inc | 0.00 |
Electromed Inc | 0.00 |
Armata Pharmaceuticals Inc | 0.00 |